- Kent Kemmish proposed “bodies on chips”: trillion-organoid, fully automated in-vitro facilities that would run massive selection/evolution campaigns on autologous human organ systems to evolve cryonics-compatible organisms and discover universal anti-aging or anti-disease interventions.  
- A rapid directed-evolution experiment was described in which iterative rounds of ice-water selection on protein libraries quickly yielded high-affinity anti-ice proteins; sequencing showed the eventual dominant variant already present after the first round, illustrating an “early-enrichment” principle.  
- Participants identified the vast clonal diversity of human B- and T-cell repertoires as the chief barrier to immune-system modeling on chips; proposed fixes range from engineering a universal monoculture immune system with “downloadable immunity” to centralized, high-throughput mutagenesis pipelines that outpace natural V(D)J recombination.  
- Enzymatic reversal of aldehyde-based tissue fixation was floated as a route to improved cryopreservation or archival biology, with speculation on designing reversible fixatives (e.g., enzyme-cleavable dialdehydes) instead of attempting to undo glutaraldehyde or formaldehyde cross-links.  
- A retracted paper (Yu-Shiun Chen et al.) claiming 50 kb DNA reads via a “protein transistor” polymerase was discussed; the associated PacBio patent US20150065353 on electron-tunneling DNA sequencing and US patent US8697469 for a “protein transistor device” were linked as evidence that industry is still exploring superconducting-DNA-like and protein-electronic concepts.  
- Additional references shared included McKendree’s 1995 NASA thesis on molecular-nanotech space architectures, Paul Fernhout’s post-scarcity economics writings, DIYbio DNA-synthesis protocol by “Peter Graham Clark,” and three Google-Group threads by Kemmish on enzymatic synthesis.